RxDoctor Payments Data

Jessica Hood, PA

Physician Assistant · Dunedin, FLNPI 1336594126

Payments from drug & device makers

$4,434in general payments, 2019–2025

Across 132 payments — averaging $33.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Procept Biorobotics Corporation$544
  • Sumitomo Pharma America, Inc.$338
  • Johnson & Johnson$303
  • Endo USA, Inc.$224
  • AbbVie$222
  • plus $1K from 17 others

What the payments were for

  • Travel & lodging$1,01323%
  • Food & beverage$3,24273%
  • Education$1804%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,434 in reported general payments places this provider in the 85th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$31,448
Medicare patients
112
Services billed
739

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban26$41,315
MounjaroTirzepatide22$22,526
Spiriva RespimatTiotropium Bromide22$17,183
MyrbetriqMirabegron17$15,617
SymbicortBudesonide/Formoterol Fumarate17$5,208
Fluticasone-SalmeterolFluticasone Propion/Salmeterol30$3,683
Novolin 70-30Insulin Nph Hum/Reg Insulin Hm11$1,533
Levothyroxine Sodium148$1,416
Rosuvastatin Calcium210$1,093
Albuterol Sulfate HfaAlbuterol Sulfate26$1,045
Pantoprazole Sodium75$876
Escitalopram Oxalate74$701
Memantine Hcl29$622
Ezetimibe23$548
Buspirone Hcl61$530

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$20$15,61717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Dunedin

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →